Recommendations for Protection Against Viral Hepatitis
Journal: Annals of Internal Medicine (1985)

Diagnosis and Treatment1 September 1985Recommendations for Protection Against Viral HepatitisRecommendation of the Immunization Practices Advisory CommitteeAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-103-3-391 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractThis statement updates all previous recommendations on use of immune globulins for protection against viral hepatitis and use of hepatitis B vaccine and hepatitis B immune globulin for prophylaxis of hepatitis B. Recommendations cover hepatitis A; hepatitis B; non-A, non-B hepatitis; and delta hepatitis. Specific indications are included for use of immune globulin, hepatitis B immune globulin, and hepatitis B vaccine for high-risk groups, including medical and dental personnel, hemodialysis patients, workers at daycare centers, workers at institutions for the mentally retarded, prison inmates, homosexual men, intravenous drug abusers, international travelers, household and sexual contacts of persons at risk, and heterosexually active persons. Recommendations are given for maternal and fetal screening for serologic markers of hepatitis B virus, and guidelines for treatment are provided.References1. FRANCIS D and MAYNARD J. The transmission and outcome of hepatitis A, B, and non-A, non-B; a review. Epidemiol Rev. 1979;1:17-31. CrossrefMedlineGoogle Scholar2. MAYNARD J. Epidemic non-A, non-B hepatitis. Semin Liver Dis. 1984;4:336-9. CrossrefMedlineGoogle Scholar3. RIZZETTO M. The delta agent. Hepatology. 1983;3:729-37. CrossrefMedlineGoogle Scholar4. Provisional public health service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR. 1985;34:1-5. Google Scholar5. KLUGE T. Gamma-globulin in the prevention of viral hepatitis: a study on the effect of medium-size doses. Acta Med Scand. 1963;174:469-77. CrossrefMedlineGoogle Scholar6. STOKES J and NEEFE J. The prevention and attenuation of infectious hepatitis by gamma globulin. JAMA. 1945;127:144-5. CrossrefGoogle Scholar7. MOSLEY J, REISLER D, BRACHOTT D, ROTH D, and WEISER J. Comparison of two lots of immune serum globulin for prophylaxis of infectious hepatitis. Am J Epidemiol. 1968;87:539-50. CrossrefMedlineGoogle Scholar8. WOODSON R and CAHILL K. Viral hepatitis abroad: incidence in Catholic missionaries. JAMA. 1972;219:1191-3. CrossrefMedlineGoogle Scholar9. WOODSON R and CLINTON J. Hepatitis prophylaxis abroad: effectiveness of immune serum globulin in protecting Peace Corps volunteers. JAMA. 1969;209:1053-8. CrossrefMedlineGoogle Scholar10. STORCH G, MCFARLAND L, KELSO K, HEILMAN C, and CARAWAY C. Viral hepatitis associated with day-care centers. JAMA. 1979;242:1514-8. CrossrefMedlineGoogle Scholar11. HADLER S, WEBSTER H, ERBEN J, SWANSON J, and MAYNARD J. Hepatitis A in day-care centers: a community-wide assessment. N Engl J Med. 1980;302:1222-7. CrossrefMedlineGoogle Scholar12. HADLER S, ERBEN J, MATTHEWS D, STARKO K, FRANCIS D, and MAYNARD J. Effect of immunoglobulin on hepatitis A in day-care centers. JAMA. 1983;249:48-53. CrossrefMedlineGoogle Scholar13. FAVERO M, MAYNARD J, LEGER R, GRAHAM D, and DIXON R. Guidelines for the care of patients hospitalized with viral hepatitis. Ann Intern Med. 1979;91:872-6. LinkGoogle Scholar14. Hepatitis B vaccine: evidence confirming lack of AIDS transmission. MMWR. 1984;33:685-7. MedlineGoogle Scholar15. KRUGMAN S, HOLLEY H, DAVIDSON M, SIMBERKOFF M, and MATSANIOTIS N. Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20 microgram and 40 microgram doses. J Med Virol. 1981;8:119-21. CrossrefMedlineGoogle Scholar16. SZMUNESS W, STEVENS C, and HARLEY E. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980;303:833-41. CrossrefMedlineGoogle Scholar17. Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR. 1985;34:105-13. MedlineGoogle Scholar18. FRANCIS D, HADLER S, and THOMPSON S. The prevention of hepatitis B with vaccine: report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982;97:362-6. LinkGoogle Scholar19. STEVENS C, ALTER H, TAYLOR P, ZANG E, HARLEY E, and SZMUNESS W. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med. 1984;311:496-501. CrossrefMedlineGoogle Scholar20. DIENSTAG J, STEVENS C, BHAN A, and SZMUNESS W. Hepatitis B vaccine administered to chronic carriers of hepatitis B surface antigen. Ann Intern Med. 1982;96:575-9. LinkGoogle Scholar21. SZMUNESS W, STEVENS C, OLESZKO W, and GOODMAN A. Passive-active immunisation against hepatitis B: immunogenicity studies in adult Americans. Lancet. 1981;1:575-7. CrossrefMedlineGoogle Scholar22. PATTISON C, MAYNARD J, BERQUIST K, and WEBSTER H. Epidemiology of hepatitis B in hospital personnel. Am J Epidemiol. 1975;101:59-64. CrossrefMedlineGoogle Scholar23. DIENSTAG J and RYAN D. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol. 1982;115:26-39. CrossrefMedlineGoogle Scholar24. MAYNARD J. Viral hepatitis as an occupational hazard in the health care profession. In: VYAS GN, COHEN SN, SCHMID R, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press; 1978:321-31. Google Scholar25. BEASLEY R, HWANG L, and LEE G. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2:1099-102. CrossrefMedlineGoogle Scholar26. WONG V, IP H, and REESINK H. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: double-blind randomised placebo-controlled study. Lancet. 1984;1:921-6. CrossrefMedlineGoogle Scholar27. STEVENS C, TOY P, and TONG M. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA. 1985;253:1740-5. CrossrefMedlineGoogle Scholar28. BEASLEY R, HWANG L, and STEVENS C. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology. 1983;3:135-41. CrossrefMedlineGoogle Scholar29. SEEFF L, WRIGHT E, and ZIMMERMAN H. Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin: final report of the Veterans Administration Cooperative Study. Ann Intern Med. 1978;88:285-93. LinkGoogle Scholar30. GRADY G, LEE V, and PRINCE A. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis. 1978;138:625-38. CrossrefMedlineGoogle Scholar31. REDEKER A, MOSLEY J, GOCKE D, MCKEE A, and POLLACK W. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med. 1975;293:1055-9. CrossrefMedlineGoogle Scholar32. SINATRA F, SHAH P, WEISSMAN J, THOMAS D, MERRITT R, and TONG M. Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis B e-positive carrier mothers. Pediatrics. 1982;70:557-9. CrossrefMedlineGoogle Scholar33. DELAPLANE D, YOGEV R, CRUSSI F, and SHULMAN S. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics. 1983;72:176-80. CrossrefMedlineGoogle Scholar34. SEEFF L and KOFF R. Passive and active immunoprophylaxis of hepatitis B. Gastroenterology. 1984;86:958-81. MedlineGoogle Scholar35. SEEFF L, ZIMMERMAN J, and WRIGHT E. A randomized, double-blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis: a Veterans Administration cooperative study. Gastroenterology. 1977;72:111-21. CrossrefMedlineGoogle Scholar36. KNODELL R, CONRAD M, GINSBURG A, BELL C, and FLANNERY E. Efficacy of prophylactic gammaglobulin in preventing non-A, non-B post-transfusion hepatitis. Lancet. 1976;1:557-61. CrossrefMedlineGoogle Scholar37. KANE M, BRADLEY D, and SHRESTHA S. Epidemic non-A, non-B hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies in marmosets. JAMA. 1984;252:3140-5. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure Information▸From the Immunization Practices Advisory Committee, Centers for Disease Control; Atlanta, Georgia. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byRecent Progress on Neutralizing Antibodies against Hepatitis B Virus and its ImplicationsSafety and pain in electrodiagnostic studiesNeonatal jaundice and liver diseaseE MERGENCY M EDICAL S ERVICES E QUIPMENT H YGIENE P RACTICESEpidemiology of hepatitis B virus in non-institutionalized children and adolescents affected by handicapRisk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnelManagement guidelines for health care workers exposed to blood and body fluidsA Meta-Analysis of Hepatitis B Serologic Marker Prevalence in EMS PersonnelViral HepatitisHealth Maintenance Strategies for Women of Different AgesVaccination in Hemodialysis PatientsCurrent immunization practicesDialysis Associated HepatitisTOWARDS THE ERADICATION OF HEPATITIS B IN AUSTRALIAViral HepatitisPREVENTION OF POST-TRANSFUSION NON-A, NON-B HEPATITIS BY NON-SPECIFIC IMMUNOGLOBULIN IN HEART SURGERY PATIENTSViral HepatitisGuiding individual decisions: A randomized, controlled trial of decision analysisHepatitis in a Chinese StudentUses of Immune Globulins in the Prophylaxis and Treatment of Viral InfectionsHepatitis B Surface Antigen in Corneal DonorsDelta Agent HepatitisHepatitis B vaccine and hepatitis B markers: Cost effectiveness of screening prehospital personnelSurgery in the Patient with Liver DiseasePoor response to hepatitis B vaccine administered to Aboriginal infants in Central AustraliaViral hepatitisRecent developments in viral hepatitisTransmission of hepatitis B from providers to patients: How big is the risk?Recommendations for Viral HepatitisDONALD J. SHERRARD, M.D.Viral Infections in Dialysis Patients Part B: Dialysis Associated Hepatitis 1 September 1985Volume 103, Issue 3 Page: 391-402 Keywords Globulins Hepatitis A Hepatitis B Hepatitis B virus Hepatitis D Homosexuals Prophylaxis Treatment guidelines Vaccines Viral diseases ePublished: 1 December 2008 Issue Published: 1 September 1985 PDF downloadLoading ...